A dyslipidemia animal model induced by poloxamer 407 in golden hamsters and pilot study on the mechanism

Yaoxue Xuebao

Volumn 46, Issue 4, 2011, Pages 406-411

  Liu, Quan ^a   Liu, Shuai Nan ^a   Li, Lin Yi ^a   Chen, Zhi Yu ^a   Lei, Lei ^a   Zhang, Ning ^a   Shen, Zhu Fang ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Dyslipidemia; Golden hamster; Lipid metabolism; Lipid lowering agent

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; CHOLESTEROL ESTER; FATTY ACID; FENOFIBRATE; MALONALDEHYDE; MESSENGER RNA; NITRIC OXIDE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; POLOXAMER; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; HYPERLIPIDEMIA; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PILOT STUDY; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SYRIAN HAMSTER; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIGENS, CD36; CRICETINAE; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FENOFIBRATE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; LIVER; MALE; MALONDIALDEHYDE; MESOCRICETUS; NITRIC OXIDE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POLOXAMER; PPAR ALPHA; PYRROLES; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 79958814964     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Derosa G, Salvadeo S, Cicero AF. Prospects for the development of novel anti-hyperlipidemic drugs [J]. Curr Opin Investig Drugs, 2006, 7: 826-833. (Pubitemid 44382789)
2. Blonder JM, Baird L, Fulfs JC, et al. Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel [J]. Life Sci, 1999, 65: 1934-1939.
3. Elahi MM, Cagampang FR, Mukhtar D, et al. Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice [J]. Br J Nutr, 2009, 102: 514-519.
4. Lloyd DJ, McCormick J, Helmering J, et al. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ld1r [J]. Am J Physiol Endocrinol Metab, 2008, 294: E496-505.
5. Zhang Z, Wang H, Jiao R, et al. Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods [J]. Mol Nutr Food Res, 2009, 53: 921-930.
6. Knopp RH, Paramsothy P, Atkinson B, et al. Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk [J]. Am J Cardiol, 2008, 101: 48B-57B.
7. Jargin SV. Discussion of evaluation of cholesterol-lowering and antioxidant properties of sugar cane policosanols in hamsters and humans [J]. Appl Physiol Nutr Metab, 2009, 34: 75; discussion 76-77.
8. Xie XY, Fu J, Gong YH. Characterization of main biological features of SPF syria golden hamster [J]. Acta Lab Anim Sci Sin, 2007, 15: 133-138.
9. Zhang L, Perdomo G, Kim DH, et al. Proteomic analysis of fructose-induced fatty liver in hamsters [J]. Metabolism, 2008, 57: 1115-1124. (Pubitemid 351997435)
10. Jang EM, Choi MS, Jung UJ, et al. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fatfed hamsters [J]. Metabolism, 2008, 57: 1576-1583.
11. Thomas PJ. The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis [J]. J Cardiovasc Pharmacol, 2004, 43: 595-606.
12. Tanaka H, Ishida T, Johnston TP, et al. Role of endothelial lipase in plasma HDL levels in a murine model of hypertriglyceridemia [J]. J Atheroscler Thromb, 2009, 16: 327-338.